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Macrophage-dependent arachidonate metabolism in hydronephrosis.
Unilateral ureteral obstruction in rabbits leads to an influx of macro-
phages into the kidney, a proliferation of interstitial cells, and an
increase in arachidonic acid metabolism. The role of the macrophage
in the metabolic changes of hydronephrosis was investigated by using
endotoxin and nitrogen mustard. The in viva administration of endo-
toxin, a macrophage agonist, 1 hour before perfusion of the hydrone-
phrotic kidney markedly enhanced (fourfold to tenfold) the peptide-
stimulated arachidonic acid metabolism of the perfused kidney. Nitro-
gen mustard made animals leukopenic and prevented the influx of
macrophages into the hydronephrotic kidney. The peptide-stimulated
arachidonic acid metabolism of these kidneys was suppressed, and no
enhancement was seen with in viva endotoxin administration. The
macrophage thus appears to be an essential determinant of the en-
hanced arachidonic acid metabolism seen in experimental hydrone-
phrosis. An inhibitory effect of prostaglandin E2 on macrophage func-
tion in this model of renal inflammation was also demonstrated. Hy-
dronephrotic animals were given aspirin during the period of unilateral
ureteral obstruction to prevent in viva prostaglandin E2 production. In
the perfused hydronephrotic kidney, the peptide-stimulated arachi-
donic acid metabolism, which appears to be a marker of macrophage
function in this model, was enhanced by aspirin treatment.
Métabolisme dépendant des macrophages de l'arachidonate lors de
l'hydronéphrose. L'obstruction urCtCrale unilatCrale chez des lapins
conduit a un afflux de macrophages dans le rein, a une proliferation des
cellules interstitielles et a une élévation du métabolisme de l'acide ar-
achidonique. Le role du macrophage dans les modifications
métaboliques de l'hydronephrose a été étudié en utilisant une endo-
toxine et une moutarde azotée. L'administration in viva d'endotoxine,
un agoniste des macrophages, I heure avant Ia perfusion du rein
hydronéphrotique a stimulé de facon marquee (4 a 10 fois) Ic
métabolisme de l'acide arachidonique stimulé par les peptides dans le
rein perfuse. La moutarde azotée a rendu les animaux leucopeniques
et a empêché l'afflux de macrophages dans le rein hydronéphrotique.
Le métabolisme stimulé par les peptides de l'acide arachidonique dans
ces reins Ctait supprimé, et aucune stimulation n'était vue lors de
l'administration in vivo d'endotoxine. Le macrophage apparaIt ainsi un
determinant essentiel de la stimulation du métabolisme arachidonique
observée lors de l'hydronephrose expérimentale. Un effet inhibiteur
des prostaglandines E2 sur Ia fonction macrophagique a également été
démontré dans cc modèle d'inflammation rénale. Les animaux
hydronephrotiques ont recu de l'aspirine pendant la periode
d'obstruction urétdrale unilatérale pour empCcher la production in vivo
de prostaglandines E2. Le métabolisme de l'acide arachidonique
stimulé par les peptides dans Ic rein hydronéphrotique perfuse, qui
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apparait comme un marqueur de la fonction macrophagique dans cc
modèle, était stimulé lors du traitement par l'aspirine.
The hydronephrotic kidney (HNK) from rabbits with uni-
lateral ureteral obstruction exhibits a markedly enhanced abil-
ity to metabolize arachidonic acid as compared to the normal
kidney [1]. It shows an increase in cyclooxygenase activity,
most notably in the cortex [2, 3]. It also shows thromboxane
synthase activity, which is absent in the normal kidney [4, 5].
The ex viva perfused HNK demonstrates a marked time-de-
pendent increase in prostaglandin E2 (PGE2) and thromboxane
A2 production when stimulated by peptide hormones (for ex-
ample, bradykinin or angiotensin II). Normal kidneys, when
perfused, produce modest amounts of PGE2 in response to pep-
tide hormones, with little change over time, and they produce
no thromboxane A2 [1, 4]. The changes in arachidonate me-
tabolism in the HNK are correlated histologically with an in-
vasion of mononuclear cells (macrophages and lymphocytes)
into the cortex, along with a proliferation of fibroblast-like in-
terstitial cells [6—81. Two lines of evidence suggest that the in-
flammatory cells are intimately related to the changes in arach-
idonate metabolism. The HNK of the cat, which produces
lesser amounts of PGE2 relative to the rabbit HNK and no
thromboxane [91, has relatively fewer mononuclear cells in its
inflammatory infiltrate [81. Furthermore, after release of the
ureteral obstruction, the rabbit HNK shows a diminished abil-
ity to synthesize PGE2 and thromboxane B2 (TXB2) when chal-
lenged with peptide hormones, and in addition, shows a dimin-
ished mononuclear cell population [81.
The hypothesis that the macrophage is the critical determi-
nant of the changes in arachidonate metabolism seen in the
HNK is suggested by a number of additional studies. Macro-
phages have been shown to synthesize a variety of prostaglan-
dins and TXB2 in culture [10—12]. They can also be stimulated
by endotoxin to produce PGE2 and to become cytolytic [13].
Endotoxin injected into the ex vivo perfused HNK causes an
immediate and sustained release of PGE2 and TXB2 [14].
In this paper, two independent strategies are used to sup-
port the hypothesis that the macrophage is an essential com-
ponent of the arachidonic acid metabolism of the HNK. First,
endotoxin, a macrophage agonist in culture, is given to hydro-
nephrotic animals in viva to establish that the peptide-stimu-
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lated arachidonic acid metabolism of the perfused HNK is a
function of an endotoxin-responsive cell. Second, nitrogen
mustard is used to render hydronephrotic animals leukopenic
and to prevent the influx of macrophages into the HNK. This
strategy demonstrates that the presence of macrophages is an
integral part of the peptide-stimulated arachidonic acid metabo-
lism of the perfused HNK.
Because PGE2 inhibits macrophage function in vitro [13, 15],
we also examine this effect in the FINK model of renal inflam-
mation. Hydronephrotic animals are given aspirin in vivo to
prevent PGE2 production. By allowing sufficient time to lapse
between the last dose of aspirin in vivo and removal of the
HNK for perfusion, we are able to follow the peptide-stimu-
lated arachidonic acid metabolism of the perfused HNK as a
marker of macrophage function and to study the effect of in
vivo inhibition of PGE2 production on macrophage function in
this model.
Methods
Materials. ['4C]-Arachidonic acid (55 mCilmole), [3H]-PGE2,
and [3H]-thromboxane B2 (100 Cilmole) were purchased from
New England Nuclear Corp. (Boston, MA). Prostaglandin
standards were kindly supplied by Dr. John Pike of the Upjohn
Company (Kalamazoo, MI). Indomethacin was the gift of
Merck, Sharp and Dohme (West Point, PA). Unlabeled arachi-
donic acid was purchased from Nu-Chek-Prep Inc. (Elysian,
MN). Endotoxin (lyophilized Escherichia coli 055:B5) was pur-
chased from Difco Laboratories (Detroit, MI). Acetylsalicylic
acid and nitrogen mustard were purchased from Sigma Chemi-
cal Co. (St. Louis, MO). Dimethyl sulfoxide (DMSO) was pur-
chased from Fischer Scientific Products (Fair Lawn, NJ).
Ureteral obstruction, treatment groups, and kidney perfu-
sion. Unilateral ureteral obstruction was carried out in male
New Zealand white rabbits (body wt, 1.5 to 2.5 kg) by a pre-
viously described procedure [16]. Briefly, animals were anes-
thetized with pentobarbital (30 mg/kg), and a small abdominal
incision was made. A silk suture was tied around the ureter of
the left kidney near the bladder. After 72 to 96 hours of ure-
teral obstruction, the hydronephrotic kidney was used in perfu-
sion experiments.
Hydronephrotic animals were divided into three groups. The
first group was rendered hydronephrotic and received no fur-
ther treatment (the control group). A second group of rabbits
was given nitrogen mustard starting 3 days prior to ureteral
obstruction. A dose of 1.75 mg/kg was given initially followed
by doses of 1 mg/kg. A total of three to six doses was given.
The efficacy of nitrogen mustard was monitored by blood
leukocyte counts. Animals were accepted for analysis only if
total leukocyte counts remained below 1500 cells/mm3 during
the period of hydronephrosis. A third group was given aspirin
twice daily beginning 2 days before unilateral ureteral obstruc-
tion and ending 12 hours before the perfusion experiment.
Each dose was 25 mg/kg of body wt, given s.c. as a 200-mg/mi
solution (in DMSO). The efficacy of this dosage of aspirin in
inhibiting cyclooxygenase was established by assaying the abil-
ity of platelets in whole blood to synthesize bioassayable
thromboxane A2 (a substance that causes contraction of the
rabbit thoracic aorta). Rabbit whole blood, 0.2-ml samples,
drawn 12 hours after the last aspirin dose, was incubated with
arachidonic acid, 0.2 mg, for 30 seconds at 370 C and then the
entire incubation mixture was assayed over a rabbit thoracic
aorta strip. Blood from aspirin-treated rabbits was compared
with the blood from untreated rabbits. With this dosage of as-
pirin, the thromboxane A2 synthesis of whole blood was inhib-
ited by greater than 90%.
Hydronephrotic animals from these three groups were then
treated with one of three further treatments: (1) endotoxin, 8
mg/kg, given 1 hour before the perfusion experiment; (2) en-
dotoxin, 2 mg/kg, given 16 hours before the perfusion experi-
ment; or (3) no endotoxin.
On the day of the perfusion experiment, the animals were an-
esthetized with pentobarbital (30 mg/kg, i.v.), they were given
heparin (250 U/kg, i.v.), and their renal arteries were cannu-
lated with polyethylene tubing. The kidney was then excised
and perfused at 25 mi/mm with oxygenated (02:C02, 95%:5%)
Krebs-Henseleit medium at 37° C. Perfusion at this rate gave
physiologic pressures (approximately 70 mm Hg). The venous
effluent was allowed to flow ever smooth muscle assay organs:
rabbit thoracic aorta (to show thromboxane A2-like activity)
and rat fundal stomach (to indicate PGE7-like activity). Indo-
methacin (0.5 g/ml) was perfused over the assay tissues to
prevent them from synthesizing prostaglandins [17].
Bradykinin injected into the ex vivo perfused kidney stimu-
lates a transient (approximately 4-minute) release of arachidon-
ate metabolites. A bolus of 300 ng of bradykinin was injected
intraarterially every hour from hours 1 to 6 of perfusion. Ve-
nous effluent was collected after each bradykinin injection for
4 mm (total, 100 ml), and aliquots were frozen (—20° C) for
subsequent radioimmunoassay (RIA).
Preparation of microsomes for radiochemical and enzyme
kinetic experiments. Microsomes were prepared as previously
described [8]. Briefly, kidneys were separated into cortex and
medulla, homogenized in phosphate buffer containing 1% BSA
and 10 m EGTA, and the x 8000g supernatant was isolated.
Microsomes were then obtained from a x lOO,000g spin (60
minutes), and the microsomal pellet resuspended in phosphate
buffer in a volume equal to one-fourth the original wet tissue
weight. The protein concentration of microsomal preparations
was determined with fluorescamine using BSA standards.
Microsomes were then incubated with ['4C]-arachidonate
(3 x 1O5 cpm, 20 nM) in the presence of 1 mM epinephrine for
30 mm at 37° C. The reaction was stopped by the addition of 4
N formic acid to bring the reaction mixture to a pH of 3.5. The
mixture was then extracted twice with two volumes of ethyl ac-
etate. The ethyl acetate extract was dried under nitrogen, re-
suspended in chloroform and methanol (2:1), and plated on
silica gel G thin-layer plates (Brinkmann Instruments, West-
bury, NY) along with unlabeled prostaglandin standards. Plates
were developed in a solvent system of chloroform, methanol,
acetic acid, and water. Prostaglandin standards were visual-
ized with iodine vapor. Plates then underwent autoradiog-
raphy by exposure to x-ray film (Kodak XAR-5, Eastman Ko-
dak Co., Rochester, NY) and were subsequently analyzed by
isolating the regions of arachidonate and its metabolites and
counting them in a liquid scintillation spectrometer.
Kinetic studies were carried out with microsomes in phos-
phate buffer (0.1 M; pH, 7.8) in a final volume of 150 nl in a
siliconized 10 x 75-mm tube. Microsomes (300 to 400 .ng of
protein) were incubated for 4 minutes at 37° C with 80 tIM of
arachidonic acid in the presence of 1 mrvi epinephrine to assess
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cyclooxygenase activity. At 80 LM of arachidonic acid, maxi-
mum velocity of cyclooxygenase was achieved [2]. The re-
action was stopped with 1.4 ml of 0° C RIA buffer. The re-
action mixture was diluted an additional tenfold before RIA
analysis. Microsomes were also diluted tenfold with phosphate
buffer and incubated with 60 M PGH2 to assess thromboxane
synthase activity according to a previously described method
[2]. Briefly, microsomes were preincubated at 37° C for 3 min-
utes and then added to a tube that contained PGH2. The mix-
ture was vortexed and incubated for 30 seconds at 370 C. A 2-
tl aliquot of the reaction mixture was added to cold RIA buffer
to terminate the reaction, and the buffer was later analyzed by
RIA.
Radioirnmunoassay. PGE2 and thromboxane B2 were im-
munoassayed with rabbit antisera as previously described [91.
Cross reactivities with other prostaglandins at 50% displace-
ment were less than 0.4% for the PGE2 antiserum and less than
0.025% for the TXB2 antiserum. The renal venous effluent col-
lected from perfused kidneys did not alter the immunoassay
standard curve for either the PGE2 or the TXB2 assay.
Histologic techniques. Hydronephrotic kidneys were rapidly
excised from anesthetized rabbits, and small fragments of cor-
tex were fixed in 2.5% glutaraldehyde in phosphate buffer. The
specimens were postfixed in 1% osmium tetroxide, dehydrated
in a series of alcohols, and embedded in Spurr's medium. Sec-
tions (1 jsm) stained with toluidine blue were examined, and,
in areas where glomeruli were present, further thin sectioning
was performed. Stained with uranyl acetate and lead citrate,
they were placed on copper grids and were then viewed in a
Philips 300 electron microscope (Philips Electronic, Mahway,
NJ) at a magnification of x 3700. Between 5 and 15 fields were
examined per kidney cortex. Numbers of interstitial cells, mac-
rophages, and lymphocytes per field examined were recorded.
All morphologic examinations were done on coded specimens.
Results
Effect of in vivo endotoxin on the arachidonic acid metabo-
lism of the perfused hydronephrotic kidney, The isolated
perfused hydronephrotic kidney, when stimulated hourly with
a fixed dose of bradykinin (BK), showed a marked increase in
the amount of TXB2 and PGE2 released between hours 1 and 6
of perfusion. As shown in Fig. 1, 8 1 ng of TXB2 were re-
leased after BK injection at hour 1, rising to 114 19 ng at
hour 6.—a greater than tenfold increase. The amount of PGE2
released by BK stimulation at hour 1 was 0.7 0.1 sg, in-
creasing to 7.7 1.4 g at hour 6 (Table 1). Normal kidneys
when perfused ex vivo produced very modest amounts of PGE2
(100 to 200 ng) in response to BK and no detectable TXB2.
Normal kidneys also showed no increase in PGE2 production
during perfusion (data not shown).
When hydronephrotic animals were given endotoxin, a
macrophage agonist, 1 hour before their kidneys were re-
moved and perfused, the amount of TXB2 produced in re-
sponse to BK at hour 1 was greater than tenfold higher than
that seen in the HNK controls (Fig. 1). At hour 1, 121 35 ng
of TXB2 were released from the HNK of the endotoxin-treated
animals versus 8 I ng from the HNK of control animals. The
amount of TXB2 released from the HNK of endotoxin-treated
animals at hour 1 was comparable to the amount released from
the HNK of control animals at hour 6 (121 35 ng versus 114
1 2 3 4 5 6
Time, hours
Fig. 1. Brad kinin-stimulated thrornboxane B2 release from perfused
hydronephrotic kidneys (HNK; N /1), HNK with endotoxin pre-
treatment 1 hour before perfusion (N = 7), and HNK with endotoxin
pretreatment 16 hours before perfusion (N 8). Results are plotted
as a function of perfusion time and represented as the mean 5EM.
Statistical comparisons are between endotoxin treatments and con-
trols, and were done with Student's t test: *JJ < 0.05; °°P < 0.01.
19, respectively). Also, the HNK from animals given endo-
toxin 1 hour before the perfusion showed little increase in the
amount of TXB2 released by BK from hours I to 6 of perfu-
sion (121 35 ng and 172 41 ng, respectively). These kid-
neys concomitantly exhibited a marked increase (roughly four-
fold) in the amount of PGE2 produced by BK stimulation at
hour 1 relative to the HNK controls (Table 1). The increase in
PGE2 production over the 6 hours of perfusion with the HNK
from endotoxin-treated animals was diminished relative to the
controls.
This response to endotoxin treatment 1 hour before the
perfusion was not specific to BK stimulation, as angiotensin II
stimulation of PGE2 and TXB2 release was similarly enhanced
(data not shown). Furthermore, endotoxin treatment 1 hour be-
fore the perfusion had no effect on either contralateral or nor-
mal kidneys, which contained no mononuclear cells and re-
leased only modest amounts of PGE2 (data not shown). Doses
of endotoxin as low as 2 mg/kg caused a result that was quan-
titatively similar to that of a 8-mg/kg dose (15-fold increase in
TXB2 at hour 1 of perfusion, N = 2).
Culture data suggest that macrophages that are activated to
become cytolytic remain cytolytic only transiently [13, 181. In
one system, macrophages treated in vitro with endotoxin were
cytolytic for 16 hours before returning to a quiescent state [13].
Therefore, the effect of in vivo endotoxin treatment for a long-
er period of time (that is, 16 hours) was determined. The effect
of endotoxin treatment given 16 hours before the perfusion dif-
fered dramatically from the effect of endotoxin given 1 hour be-
fore the perfusion. The HNK from animals that received en-
dotoxin 16 hours before the kidney was removed and perfused
exhibited relatively suppressed levels of TXB2 and PGE2 pro-
duced by BK stimulation. TXB2 production in response to BK
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Fig. 2. Electron micrographsfro,n the cortex
of a control hydronephrotic kidney (HNK) (at
left) and the cortex from an HNK from a
nitrogen mustard-treated animal (at right).
The interstitial space between the renal
tubules (t) is widened in both kidneys. Both
interstitial (i.e.) cells and macrophages (m) are
abundant in the control HNK. Although
interstitial cells are still prominent in the
HNK from the nitrogen mustard-treated
animal, there is a virtual absence of
macrophages. Red blood cells are denoted by
r. (Uranyl acetate and lead citrate stain;
magnification, x 3000)
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Table 1. Bradykinin-stimulated PGE2 release in the hydronephrotic kidney*
in these kidneys went from 13 5 ng at hour I to 28 8 ng
at hour 6 (Fig. 1), whereas PGE2 production went from 1.0
0.3 tg at hour Ito 2.3 0.6 g at hour 6 (Table 1). The levels
of these arachidonate metabolites at hour 6 were approxi-
mately one third to one fourth of those seen in the HNK con-
trols at hour 6 of perfusion.
No obvious histologic changes were noted by electron mi-
croscopy in the HNK from animals given endotoxin either 1 or
16 hours before perfusion.
Effect of nitrogen mustard treatment on the arachidonic acid
metabolism of the perfused hydronephrotic kidney. Nitrogen
mustard was used to render animals leukopenic and thereby
prevent the influx of mononuclear cells into the HNK. The
HNK from these animals showed a marked depletion of mac-
rophages on electron microscopy relative to the untreated
HNK but a still prominent number of interstitial cells (Fig. 2).
When cell numbers were quantified, there were comparable
numbers of interstitial cells in the HNK from both control and
nitrogen mustard-treated animals, though lymphocytes were
moderately reduced in the latter group (Table 2). Macro-
phages, however, were almost completely absent in the nitro-
gen mustard group although present in substantial numbers in
the control group (Table 2).
When perfused, the HNK from nitrogen mustard-treated ani-
Experimental
Total no. of
cells per
Interstitial
cells per
Macro-
phages
Lympho-
cytes per
group field field per field field
Control (N = 6)
Nitrogen mustard
5.3 0.4 3.2 0.3 1.3 0.2 0.8 0.2
group (N = 5) 3.0 0.2 2.7 0.2 <0.1 0.3 0.1
mals showed a marked attenuation of the amount of TXB2 and
PGE2 released with hourly 13K stimulation. TXB2 release at
hour 6 was 19 2 ng; less than one fifth of that seen in the
perfused HNK from control animals (Fig. 3). PGE2 release at
hour 6 was 2.9 0.3 g; less than one half of that seen in the
perfused HNK from control animals (Table 1). Nitrogen mus-
tard treatement also prevented the enhancement of TXB2 (Fig.
4) and PGE2 release from the perfused HNK seen with endo-
toxin treatment in vivo 1 hour prior to perfusion. As shown
above, endotoxin treatment in vivo 1 hour before the HNK
from control animals was removed and perfused markedly en-
hanced peptide-stimulated TXB2 and PGE2 release relative to
Control
Perfusion time (N = 11)
With endotoxin
With nitrogen
mustard
(N = 4)
With aspirin
in vivo
(N = 4)
Given 1 hour
prior to perfusion(N = 7)
Given 16 hours
prior to perfusion
(N 8)
1 hour 0.7 0.1 2.4 0.6** 1.0 0.3 0.3 0.1 0.3 0.1
2 hours 0.9 0.2 2.5 0.7* 1.0 0.3 0.5 0.1 1.1 0.2
3 hours 1.3 0.3 4.0 l.1** 0.9 0.3 0.7 0.1 2.8 0.4**
4 hours 2.3 0.5 7.0 l.9** 1.0 0.3* 1.1 0.1* 8.5 l.6**
5 hours 5.7 1.5 9.3 2.2 1.5 0.4* 2.6 0.2 9.6 1.6
6 hours 7.7 l.4 9.7 2.3 2.3 0.6** 2.9 0.3** 11.2 2.2
Results are expressed as micrograms of PGE2 released from the perfused kidney after a bolus of brad ykinin (see Methods). Values are the
means SEM. Significance, determined relative to the HNK controls by Student's t test, is denoted by asterisks: * < 0.05; ** < 0.01.
Table 2. Relative cellularity of the cortex of the hydronephrotic
kidney from control and nitrogen mustard-treated animalsa
° The measurement of the number of cells per field is described in
Methods.
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animals not given endotoxin. However, when endotoxin was
similarly given to hydronephrotic animals rendered leukopenic
with nitrogen mustard, peptide-stimulated TXB2 release from
the perfused HNK was not significantly greater than that seen
from the HNK from nitrogen mustard-treated animals not
given endotoxin, and markedly less than that seen from the
HNK from animals given endotoxin in vivo 1 hour before
perfusion (Fig. 4). PGE2 release from these kidneys was also
diminished relative to the HNK from animals given endotoxin
in vivo 1 hour before perfusion (data not shown).
Cyclooxygenase activity in cortical microsomes from the
HNK from nitrogen mustard-treated animals was comparable
to that of the control HNK, although microsomes from both of
* these kidneys were threefold more active in metabolizing ['4C]-
arachidonic acid than were cortical microsomes from the nor-
mal kidney (Fig. 5). Only cortical microsomes from the control
HNK formed discernible TXB2 (Fig. 5). Medullary mi-
crosomes from normal kidney, the control HNK, and the HNK
from nitrogen mustard-treated animals were equally active in
their ability to metabolize ['4C]-arachidonic acid, but again
only the control HNK formed a significant amount of TXB2
(Fig. 5). Kinetic data indicated that the Vmax of the cortical cy-
clooxygenase was the same in the HNK from control and ni-
trogen mustard-treated animals (Table 3). The Vmax of cortical
thromboxane synthase from the control HNK, however, was
four times that from the HNK from nitrogen mustard-treated
animals (Table 3). Thus, it appeared that nitrogen mustard
treatment selectively reduced the thromboxane synthase ac-
tivity in the HNK.
Effect of chronic aspirin treatment on the arachidonic acid
metabolism of the perfused hydronephrotic kidney. PGE2 has
been shown to be an inhibitor of macrophage function in vitro
[13, 15], thus the effect of chronic in vivo suppression of PGE2
production on the arachidonic acid metabolism of the perfused
HNK was investigated. Animals were treated with aspirin dur-
ing the period of unilateral ureteral obstruction to inhibit PGE2
synthesis in vivo. Aspirin treatment was stopped 12 hours be-
fore perfusion to allow time for the renal cyclooxygenase to re-
cover. The HNK was then removed and perfused, and pep-
100
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30 —
Nitrogen
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AA
0)0
a)0)
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a)
02
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8 TxB2
. 10 — F2,,I-
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5 U Normal HNK HNK + N. must.
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Fig. 5. Autoradiogram of the thin-layer chromatographic separation of
Time, hours the arachidonate metabolites produced by microsomes from normal
Fig. 3. Bradykinin-induced thromboxane B2 release from the hydro- kidney and from hydronephrotic kidneys (HNK) that were treated or
nephrotic kidney (HNK) from control (N = 11) and nitrogen mustard- not treated (control) with nitrogen mustard (N. must.). Cortical (cort.)
treated animals (N 4). Hydronephrotic animals were given 3.75 to or medullary (med.) microsomes were incubated with ['4C1-arachi-
6.75 mg/kg of nitrogen mustard to induce leukopenia during the period donic acid (see Methods) and the resultant metabolites identified using
of unilateral ureteral obstruction. Results are expressed as the mean thin-layer chromatography and autoradiography. Metabolites were
SEM. Statistical comparisons are between nitrogen mustard and con- identified by comigration with authentic standards. Plates were ana-
trol animals: * < 0.05. lyzed further by isolating and counting the regions of arachidonic acid
(AA), PGD2 (D2), PGE2 (E2), thromboxane B2 (TXB2), and PGF2,.
(F2).
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Fig. 4. Bradykinin-stimulated thromboxane B2 release from perfused
hydronephrotic kidneys from control (N = 7) and nitrogen mustard-
treated animals (N = 4) given endotoxin 1 hour before the HNK was
removed and perfused. Means SEM are shown. Statistical compari-
sons are between groups shown: 0P < 0.05; ** < 0.01.
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Enzymatic
reaction
V,ax, p,noles/mg of protein/mm
Normal
kidney
HNK
Without nitrogen
mustard
With nitrogen
mustard
AA —* PGE2
H2 — TXB2
26 2 200 36(N = 5) (N = 10)
723 233 2255 385
(N'=3) (N=4)
206 53
(N = 4)
558 90*
(N=4)
**
-
*/ Aspirin treatmentin vivo
Controls
//
-
I I
1 2 3 4 5 6
Time, hours
Fig. 6. Bradykinin-stimulated thromboxane B2 release from perfused
hydronephrotic kidneys from control (N = II) and aspirin-treated ani-
mals (N = 4). Aspirin, 25 mg/kg, was given from 48 hours before uni-
lateral ureteral obstruction until 12 hours before perfusion. Results are
plotted as the means SEM. Statistical comparisons are between con-
trol and aspirin-treated animals: < 0.01.
tide-stimulated arachidonic acid metabolism was followed as a
marker of macrophage function. The HNK from these animals
released levels of TXB2 in response to BK which were from
two to four times higher than that seen in the HNK controls
from hours 2 through 6 of perfusion (Fig. 6). No difference was
seen at hour 1, probably as a result of residual cyclooxygenase
inhibition by aspirin. PGE2 release was similarly greater in
these kidneys (Table 1). The TXB2 and PGE2 release by the
HNK from vehicle-treated hydronephrotic animals was in-
distinguishable from that of the HNK from controls (data not
shown).
In vitro studies also show that macrophages can be stimu-
lated by endotoxin to become transiently cytolytic [13]. Analo-
gously, the arachidonic acid metabolism of the HNK, which
appeared to be a function of the macrophage, was transiently
enhanced by in vivo endotoxin. In culture, the period of cyto-
lytic activity of macrophages stimulated with endotoxin is pro-
longed by cyclooxygenase inhibition [13]. Consequently, the
effect of chronic aspirin treatment on the duration of enhanced
arachidonic acid metabolism seen with in vivo endotoxin was
determined. Endotoxin treatment in vivo 1 hour before perfu-
sion was given to hydronephrotic animals who were aspirin-
treated and to controls. The peptide-stimulated production of
TXB2 and PGE2 of the HNK did not differ between the two
groups and appeared to be at a maximum (data not shown).
However, when endotoxin was given in vivo 16 hours before
perfusion to aspirin-treated and control hydronephrotic ani-
mals, the HNK from the aspirin-treated group released more
than three times as much TXB2 and PGE2 in response to BK.
At hour 6, these kidneys released 87 16 ng of TXB2 and 7.7
0.6 g of PGE2 in response to BK. The corresponding con-
trols released 28 8 ng of TXB2 and 2.3 0.6 g of PGE2 (P
<0.01 for both comparisons). Therefore, aspirin treatment ap-
peared to prolong the period of enhanced peptide-stimulated
arachidonic acid metabolism in the HNK elicited by in vivo en-
dotoxin treatment.
Discussion
Ureteral obstruction of the rabbit kidney causes mononu-
clear cell infiltration, interstitial cell proliferation, and a marked
increase in arachidonic acid metabolism [8]. The relationship
between the mononuclear cell infiltrate and the changes in ara-
chidonic acid metabolism is suggested by the demonstration
that relief of the obstruction reverses the enhancement of peptide-
stimulated PGE2 and TXB2 release and also reduces the mono-
nuclear cell population [8]. The relationship between the in-
flammatory cell infiltrate and the enhanced arachidonic acid
metabolism in the HNK is strengthened by the demonstration
that endotoxin injected into the perfused HNK causes a sus-
tained release of PGE2 and TXB2 but does not affect the
perfused postobstructed or normal kidney [8, 14].
In this paper, the macrophage has been identified as an es-
sential component of the enhanced arachidonic acid metabo-
lism of HNK using two strategies: in vivo endotoxin treatment
and nitrogen mustard treatment. Endotoxin causes macro-
phages to synthesize PGE2 and TXB2 in vitro [12, 13, 19] and
activates macrophages to become cytolytic [13, 20]. Corre-
spondingly, endotoxin injected 1 hour before perfusion into
animals made hydronephrotic caused a marked increase in pep-
tide-stimulated PGE2 and TXB2 release from the perfused
HNK. In support of the assertion that endotoxin acted specifi-
cally through the macrophage, it was shown that nitrogen mus-
tard markedly reduced the macrophage number in the HNK
and abolished the response to endotoxin injected 1 hour before
perfusion. The effect of endotoxin on the HNK also appeared
to be time-dependent; that is, endotoxin injected 1 hour before
perfusion caused an enhancement of the PGE2 and TXB2 re-
lease by the perfused HNK, whereas endotoxin injected 16
hours before perfusion suppressed the PGE2 and TXB2 release
by the HNK. This result is analogous to the observation that
macrophages in vitro become cytotoxic transiently and even-
tually revert back to a quiescent state [13, 18]. The critical role
of the macrophage in the enhanced arachidonate metabolism of
the HNK was also supported by the observation that nitrogen
Table 3. Comparative metabolic rates of cortical microsomes from
normal kidney, the hydronephrotic kidney (HNK), and the HNK
from nitrogen mustard-treated animalsa
Abbreviations: AA, arachidonic acid; H2, prostaglandin H2.
a Statistical significance between the two HNK groups is denoted by
an asterisk: * < 0.05.
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Fig. 7. Schematic representation of the role of the macrophage in hy-
dronephrosis. Unilateral ureteral obstruction induces mononuclear cell
invasion and interstitial cell proliferation. Macrophages may stimulate
the interstitial cells via a factor (mononuclear cell factor, MNCF). In-
terstitial cells produce PGE2, which may inhibit macrophages and play
a role in postobstructive diuresis. Macrophages produce thromboxane
A2 (TXA2) possibly from arachidonic acid (AA) released from inter-
stitial cells. Thromboxane A2 may mediate the vasoconstriction of hy-
dronephrosis. Macrophages can be activated by the in vivo adminis-
tration of endotoxin. Other abbreviations used are BK, bradykinin;
PL, phospholipid; PGH2, prostaglandin H2.
mustard treatment, which prevented the macrophage infiltra-
tion, diminished the peptide-stimulated PGE2 and TXB2 re-
lease seen in the perfused HNK.
PGE2 is an in vitro inhibitor of macrophage cytolytic activ-
ity [13, 15] and is responsible for the suppression of endo-
toxin-induced cytotoxicity after 16 hours of culture [131. A po-
tential role for PGE2 as an inhibitor of macrophage function in
this model of inflammation was suggested by the use of chronic
aspirin treatment, When hydronephrotic animals were given
aspirin in such a way to inhibit in vivo PGE2 production with-
out affecting the arachidonic acid metabolism of the perfused
HNK, which was used as a marker of macrophage function,
the perfused HNK exhibited an enhanced peptide-stimulated
production of TXB2 and PGE2. Additionally, aspirin treatment
prolonged the period of enhanced arachidonic acid metabolism
seen with in vivo endotoxin treatment. These results suggest
that PGE2 inhibits macrophage function in experimental hydro-
nephrosis.
Although the cellular location of PGE2 and thromboxane A2
production remains unresolved, the nitrogen mustard experi-
ments suggested that the macrophage was the predominant
source of thromboxane A2 in the HNK. Macrophages in vitro
synthesize a host of arachidonate metabolites, including PGE2
and TXB2 [10—121, and produce a factor that stimulates PGE2
synthesis by fibroblasts [21, 22]. With nitrogen mustard, it was
possible to prevent the macrophage infiltrate and selectively re-
duce the thromboxane synthase activity in the HNK. TXB2
production in the perfused HNK, however, was a result of bra-
dykinin (BK) stimulation. Cultured macrophages do not re-
spond to BK, although cultured fibroblasts do [23, 24]. None-
theless, there is precedent for the transfer between inflamma-
tory cells of arachidonic acid and its metabolites: macrophages
can utilize arachidonic acid released from lymphocytes to form
TXB2 [25], and neutrophils can utilize 12-hydroxyeicosatet-
raenoic acid released from platelets to form 5,12-dihydroxyei-
cosatetraenoic acids [261. This evidence suggests that the
macrophage need not have a BK receptor for it to contribute
to the enhanced TXB2 synthesis seen with BK administration
to the perfused HNK.
In light of the observations in this paper, the model for the
changes occurring in the HNK recently proposed by our group
181 should be amended as shown in Fig. 7. Ureteral obstruc-
tion leads to the influx of macrophages, which interact with the
resident interstitial cells, leading to interstitial cell prolifera-
tion, enhanced PGE2 production, and thromboxane A2 produc-
tion. The macrophages present in the HNK are in resting state
but can be activated by the in vivo administration of endo-
toxin and probably by ex vivo perfusion. The PGE2 produced
in the HNK may inhibit in vivo macrophage activity. Throm-
boxane A2 and PGE2 potentially mediate the vasoconstriction
in hydronephrosis and postobstructive diuresis, respectively
[27, 281. The key role of the macrophage in this model of in-
flammation is analogous to that of the macrophage in glomeru-
lonephritis, where this cell is an essential component of
glomerular damage [29, 301, and suggests that the macrophage
may be a pivotal cell in numerous forms of inflammation.
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